Home Other Building Blocks 2-(4-Chlorophenoxy) propionic acid

2-(4-Chlorophenoxy) propionic acid

CAS No.:
3307-39-9
Catalog Number:
AG0029CU
Molecular Formula:
C9H9ClO3
Molecular Weight:
200.6190
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$63
- +
5g
98%
In Stock USA
United States
$188
- +
10g
98%
In Stock USA
United States
$313
- +
25g
98%
In Stock USA
United States
$563
- +
Product Description
Catalog Number:
AG0029CU
Chemical Name:
2-(4-Chlorophenoxy) propionic acid
CAS Number:
3307-39-9
Molecular Formula:
C9H9ClO3
Molecular Weight:
200.6190
MDL Number:
MFCD00002647
IUPAC Name:
2-(4-chlorophenoxy)propanoic acid
InChI:
InChI=1S/C9H9ClO3/c1-6(9(11)12)13-8-4-2-7(10)3-5-8/h2-6H,1H3,(H,11,12)
InChI Key:
DKHJWWRYTONYHB-UHFFFAOYSA-N
SMILES:
CC(C(=O)O)Oc1ccc(cc1)Cl
EC Number:
221-991-8
NSC Number:
70174
Properties
Complexity:
176  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
200.024g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
200.618g/mol
Monoisotopic Mass:
200.024g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
46.5A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Toxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning. Toxicology letters 20110325
Purification and gene cloning of an enantioselective thioesterification enzyme from Brevibacterium ketoglutamicum KU1073, a deracemization bacterium of 2-(4-chlorophenoxy)propanoic acid. Bioscience, biotechnology, and biochemistry 20100101
Physiology and pathophysiology of ClC-K/barttin channels. Frontiers in physiology 20100101
Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels. Frontiers in pharmacology 20100101
Combined use of biomarkers and in situ bioassays in Daphnia magna to monitor environmental hazards of pesticides in the field. Environmental toxicology and chemistry 20070201
Radiolytic degradation of herbicide 4-chloro-2-methyl phenoxyacetic acid (MCPA) by gamma-radiation for environmental protection. Ecotoxicology and environmental safety 20061001
Differential effects of pyrazinamide and clofibrate on gene expression of rat hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme of the tryptophan-NAD pathway. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 20060501
Channel or transporter? The CLC saga continues. Experimental physiology 20060101
Activation and inhibition of kidney CLC-K chloride channels by fenamates. Molecular pharmacology 20060101
Diversity of Cl(-) channels. Cellular and molecular life sciences : CMLS 20060101
Phenoxyacetic acid herbicide exposure for women on Ontario farms. Journal of toxicology and environmental health. Part A 20050813
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO reports 20040601
CLC-K channels: if the drug fits, use it. EMBO reports 20040601
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers. Journal of the American Society of Nephrology : JASN 20040101
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1. British journal of pharmacology 20030801
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Molecular pharmacology 20020801
Exposure to pesticides as risk factor for non-Hodgkin's lymphoma and hairy cell leukemia: pooled analysis of two Swedish case-control studies. Leukemia & lymphoma 20020501
Fast and slow gating of CLC-1: differential effects of 2-(4-chlorophenoxy) propionic acid and dominant negative mutations. Molecular pharmacology 20010701
[Pharmacological analysis of the antihypoxic action of aminobutyric acid derivatives]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20010101
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Molecular pharmacology 20000901
Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid. British journal of pharmacology 19990301
Properties